882 related articles for article (PubMed ID: 21810685)
21. The impact of low-grade toxicity in older people with cancer undergoing chemotherapy.
Kalsi T; Babic-Illman G; Fields P; Hughes S; Maisey N; Ross P; Wang Y; Harari D
Br J Cancer; 2014 Dec; 111(12):2224-8. PubMed ID: 25268369
[TBL] [Abstract][Full Text] [Related]
22. Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer.
Zauderer M; Patil S; Hurria A
Breast Cancer Res Treat; 2009 Sep; 117(1):205-10. PubMed ID: 18622739
[TBL] [Abstract][Full Text] [Related]
23. Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients.
Aparicio T; Jouve JL; Teillet L; Gargot D; Subtil F; Le Brun-Ly V; Cretin J; Locher C; Bouché O; Breysacher G; Charneau J; Seitz JF; Gasmi M; Stefani L; Ramdani M; Lecomte T; Mitry E
J Clin Oncol; 2013 Apr; 31(11):1464-70. PubMed ID: 23460711
[TBL] [Abstract][Full Text] [Related]
24. Utility of a chemotherapy toxicity prediction tool for older patients in a community setting.
Mariano C; Jamal R; Bains P; Hejazi S; Chao L; Wan J; Ho J
Curr Oncol; 2019 Aug; 26(4):234-239. PubMed ID: 31548802
[TBL] [Abstract][Full Text] [Related]
25. Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.
Hurria A; Brogan K; Panageas KS; Pearce C; Norton L; Jakubowski A; Zauderer M; Howard J; Hudis C
Breast Cancer Res Treat; 2005 Jul; 92(2):151-6. PubMed ID: 15986124
[TBL] [Abstract][Full Text] [Related]
26. The performance of three oncogeriatric screening tools - G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study.
Kotzerke D; Moritz F; Mantovani L; Hambsch P; Hering K; Kuhnt T; Yahiaoui-Doktor M; Forstmeyer D; Lordick F; Knödler M
J Geriatr Oncol; 2019 Nov; 10(6):937-943. PubMed ID: 31085136
[TBL] [Abstract][Full Text] [Related]
27. Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study.
Kim JW; Lee YG; Hwang IG; Song HS; Koh SJ; Ko YH; Shin SH; Woo IS; Hong S; Kim TY; Kim SY; Nam BH; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Bae SH; Koo DH; Kim KI; Kim JH
Br J Cancer; 2018 May; 118(9):1169-1175. PubMed ID: 29576622
[TBL] [Abstract][Full Text] [Related]
28. The predictive value of G8 and the Cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer.
Chan WL; Ma T; Cheung KL; Choi H; Wong J; Lam KO; Yuen KK; Luk MY; Kwong D
J Geriatr Oncol; 2021 May; 12(4):557-562. PubMed ID: 33127385
[TBL] [Abstract][Full Text] [Related]
29. Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer.
Chrischilles EA; Pendergast JF; Kahn KL; Wallace RB; Moga DC; Harrington DP; Kiefe CI; Weeks JC; West DW; Zafar SY; Fletcher RH
J Clin Oncol; 2010 Feb; 28(4):620-7. PubMed ID: 20038726
[TBL] [Abstract][Full Text] [Related]
30. Prospective phase I-II trial of helical tomotherapy with or without chemotherapy for postoperative cervical cancer patients.
Schwarz JK; Wahab S; Grigsby PW
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1258-63. PubMed ID: 20932657
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx).
Cheng HL; Molassiotis A
Asia Pac J Clin Oncol; 2019 Feb; 15(1):56-62. PubMed ID: 29873180
[TBL] [Abstract][Full Text] [Related]
32. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study.
Extermann M; Chen H; Cantor AB; Corcoran MB; Meyer J; Grendys E; Cavanaugh D; Antonek S; Camarata A; Haley WE; Balducci L
Eur J Cancer; 2002 Jul; 38(11):1466-73. PubMed ID: 12110492
[TBL] [Abstract][Full Text] [Related]
33. Toxicity of intraperitoneal chemotherapy and risk factors for severe toxicity in optimally debulked ovarian cancer patients.
Koo YJ; Lim KT
Taiwan J Obstet Gynecol; 2015 Jun; 54(3):275-9. PubMed ID: 26166340
[TBL] [Abstract][Full Text] [Related]
34. Prediction of acute toxicity grade ≥ 3 in patients with locally advanced non-small-cell lung cancer receiving intensity modulated radiotherapy and concurrent low-dose Cisplatin.
Uyterlinde W; Belderbos J; Baas C; van Werkhoven E; Knegjens J; Baas P; Smit A; Rikers C; van den Heuvel M
Clin Lung Cancer; 2013 Sep; 14(5):541-8. PubMed ID: 23835165
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the CARG tool, the VES-13, and oncologist judgment in predicting grade 3+ toxicities in men undergoing chemotherapy for metastatic prostate cancer.
Alibhai SM; Aziz S; Manokumar T; Timilshina N; Breunis H
J Geriatr Oncol; 2017 Jan; 8(1):31-36. PubMed ID: 27756545
[TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
37. Association of multidimensional comorbidities with survival, toxicity, and unplanned hospitalizations in older adults with metastatic colorectal cancer treated with chemotherapy.
Kim KH; Lee JJ; Kim J; Zhou JM; Gomes F; Sehovic M; Extermann M
J Geriatr Oncol; 2019 Sep; 10(5):733-741. PubMed ID: 30765268
[TBL] [Abstract][Full Text] [Related]
38. A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417.
Schefter TE; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Gaffney DK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1179-84. PubMed ID: 22342094
[TBL] [Abstract][Full Text] [Related]
39. Chemotoxicity recurrence in older patients: Risk factors and effectiveness of preventive strategies-a prospective study.
Extermann M; Reich RR; Sehovic M
Cancer; 2015 Sep; 121(17):2984-92. PubMed ID: 26033177
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors for Hospitalizations Among Older Adults with Gastrointestinal Cancers.
Li D; Sun CL; Allen R; Crook CJ; Levi A; Ballena R; Klepin HD; Elias R; Mohile SG; Tew WP; Owusu C; Muss HB; Lichtman SM; Gross CP; Chapman AE; Gajra A; Cohen HJ; Katheria V; Hurria A; Dale W
Oncologist; 2022 Feb; 27(1):e37-e44. PubMed ID: 35305099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
